BAD updates guideline on biologic therapy for psoriasis

The British Association of Dermatologists (BAD) has updated its guideline on biologic therapy for psoriasis. The guideline, which is accredited by NICE, provides evidence-based recommendations on the use of biologic therapies (including adalimumab, etanercept, infliximab, ixekizumab, secukinumab, and ustekinumab) in adults, children, and young people for the treatment of psoriasis. ...

Please register to continue reading this content

Register for free

Guidelines for Nurses is completely free for UK-based doctors, nurses, and pharmacists